Prima BioMed Ltd (PBMD.OQ)

PBMD.OQ on NASDAQ Stock Exchange Global Market

0.98USD
29 Sep 2014
Price Change (% chg)

$-0.02 (-2.00%)
Prev Close
$1.00
Open
$0.98
Day's High
$0.98
Day's Low
$0.98
Volume
40
Avg. Vol
5,229
52-wk High
$1.94
52-wk Low
$0.82

PBMD.OQ

Chart for PBMD.OQ

About

Prima BioMed Ltd is a biotechnology company is engaged in the research, development and commercialization of licensed medical biotechnology. The Company focuses on the the development of personalized immunocellular therapeutic products for the treatment of cancer. The Company’s lead product is CVac is an autologous dendritic... (more)

Overall

Beta: 1.76
Market Cap (Mil.): $47.92
Shares Outstanding (Mil.): 1,228.71
Dividend: --
Yield (%): --

Financials

  PBMD.OQ Industry Sector
P/E (TTM): -- 130.98 33.98
EPS (TTM): -0.01 -- --
ROI: -51.46 -2.16 17.39
ROE: -51.48 -7.09 18.24
Search Stocks

Prima BioMed's therapy improves survival rates in ovarian cancer

- Prima BioMed Ltd said its experimental lead treatment improved survival in some ovarian cancer patients without the disease worsening.

14 May 2014

Prima BioMed's therapy improves survival rates in ovarian cancer

May 14 - Prima BioMed Ltd said its experimental lead treatment improved survival in some ovarian cancer patients without the disease worsening.

14 May 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$250.00
Provider: Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks